This inventor holds 1 USPTO granted patent. Top assignees: Quiver Bioscience, Inc., Quiver Holdings Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2026
Title: James Fink - Innovator in Therapeutics
Introduction
James Fink is a notable inventor recognized for his contributions to the field of therapeutics. He has developed innovative solutions aimed at addressing specific medical conditions, particularly focusing on SYNGAP haploinsufficiency. His work has the potential to significantly impact the lives of those affected by this condition.
Latest Patents
James Fink holds 1 patent for his invention titled "Therapeutics for SYNGAP Haploinsufficiency." This patent represents a significant advancement in therapeutic options for patients suffering from this genetic disorder.
Career Highlights
Throughout his career, James has worked with various companies, including Quiver Holdings Inc. and Quiver Bioscience, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of therapeutics.
Collaborations
James has collaborated with several professionals in his field, including Matt McCabe and Graham T. Dempsey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James Fink is a dedicated inventor whose work in therapeutics is paving the way for new treatments for SYNGAP haploinsufficiency. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile